Indication
Vulvovaginal candidiasis
Vulvovaginal candidiasis is an opportunistic fungal infection of the lower female reproductive tract, primarily involving the vaginal mucosa and vulvar epithelium. Read more about Vulvovaginal candidiasis
248 drugs 85 manufacturers
Drugs that treat it
Common Vulvovaginal candidiasis therapies.
TERCONAZOLE
TERCONAZOLE
MICONAZOLE 3 (miconazole nitrate)
AVC VAGINAL (sulfanilamide)
GYNAZOLE 1 (butoconazole nitrate)
TERCONAZOLE
MONISTAT 7 (miconazole nitrate)
MICONAZOLE 3 (miconazole nitrate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonVulvovaginal candidiasis is an opportunistic fungal infection of the lower female reproductive tract, primarily involving the vaginal mucosa and vulvar epithelium.
Most frequently caused by an overgrowth of *Candida albicans*, it commonly affects reproductive-aged women when alterations in host vaginal defenses, the local microbiome, or hormone levels trigger a shift from commensal colonization to pathogenic hyphal invasion.
The condition is clinically characterized by intense vulvar pruritus, burning, soreness, dyspareunia, and external dysuria, often accompanied by erythema, edema, and a thick, curd-like white vaginal discharge against a typically normal vaginal pH.
- nih.gov
Vulvovaginal candidiasis is an opportunistic fungal infection of the lower female reproductive tract, primarily involving the vaginal mucosa and vulvar epithelium Most frequently caused by an overgrowth of *Candida albicans*, it commonly affects reproductive-aged women when alterations in host vaginal defenses, the local microbiome, or hormone levels trigger a shift from commensal colonization to pathogenic hyphal invasion The condition is clinically characterized by intense vulvar pruritus, bur...
- nih.gov
Vulvovaginal candidiasis is an opportunistic fungal infection of the lower female reproductive tract, primarily involving the vaginal mucosa and vulvar epithelium Most frequently caused by an overgrowth of *Candida albicans*, it commonly affects reproductive-aged women when alterations in host vaginal defenses, the local microbiome, or hormone levels trigger a shift from commensal colonization to pathogenic hyphal invasion
- cdc.gov
Most frequently caused by an overgrowth of *Candida albicans*, it commonly affects reproductive-aged women when alterations in host vaginal defenses, the local microbiome, or hormone levels trigger a shift from commensal colonization to pathogenic hyphal invasion The condition is clinically characterized by intense vulvar pruritus, burning, soreness, dyspareunia, and external dysuria, often accompanied by erythema, edema, and a thick, curd-like white vaginal discharge against a typically normal ...
Personalize your experience
Follow Vulvovaginal candidiasis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.